← Leaderboards
Jessica Alber
University Of Rhode Island
$8,807,713
Attributed
$8,807,713
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,807,713 · 2
By mechanism
R01$8,348,817 · 1
R21$458,896 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rhode Island
Same institution · by research overlap
- Laurie Ruggiero$4,777,089
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseOphthalmoscopyInner Plexiform LayerOphthalmologyAlzheimer Disease ScreeningDetectionBrainGeneral PopulationInfrastructureCerebrumNeurodegenerative DisordersBiological MarkersBiomarker DevelopmentCerebrospinal FluidCostAmyloid Beta-ProteinCost EfficientFunctional LossGanglion CellImageImpaired CognitionEvaluationLasers
Grant awards (5)
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease$1,984,309
R01 · FY2025 · AG · contact PI
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease$1,786,110
R01 · FY2024 · AG · contact PI
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease$2,012,035
R01 · FY2023 · AG · contact PI
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease$2,566,363
R01 · FY2022 · AG · contact PI
Development of Retinal Biomarkers in Autosomal Dominant Alzheimer's Disease: A pilot study$458,896
R21 · FY2021 · AG · contact PI